Navigation Links
AMA Rejects PBS 'Measure and Share' Proposals

The AMA Federal Council has rejected outright Pharmaceutical Benefits Scheme (PBS) 'measure and share' proposals, which are currently being pushed by some medical groups. //

AMA President, Dr Mukesh Haikerwal, said today that any PBS savings derived from changed prescribing patterns must be re-invested back into the PBS.

'Evidence-based prescribing information and other education strategies, including details of comparative prescribing patterns, contribute to improvements in the quality use of medicines,' Dr Haikerwal said.

The AMA supports the education activities of the National Prescribing Service, particularly at the local level, which include:

  • The provision of independent, evidence-based information regarding best practice prescribing and use of medicines


  • The development and implementation of opportunities for GPs to participate in peer review of prescribing


  • The development and dissemination of public education regarding quality use of medicines


  • Dr Haikerwal said that rather than pursuing 'measure and share' programs, the AMA wants the Government to boost National Prescribing Service resources and funding to allow them to broaden the range and reach of their services.

    'The AMA emphasises that any PBS savings derived from Quality Use of Medicines activities must be retained within the PBS to benefit all Australians.

    'There should never be any doubt that prescribing is best practice and patient-centred, and there are no ulterior motives attached to treatments prescribed,' Dr Haikerwal said.
    '"/>




    Page: 1

    Related medicine news :

    1. Games Event Rejects Prior Transplant Patient
    2. Court Rejects Case of Negligence by Disabled Children against the Doctors
    3. Apex Consumer Court Rejects Rs 143 Cr Medical Negligence Claim
    4. Spanish Fashion Show Rejects Five Models as too Thin
    5. Single Women and Lesbians To Enjoy Full Rights in Donor Child Proposals
    6. Tuberculosis Experts Outline Proposals to Speed Up Drug Development
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
    (Date:3/28/2017)... ... March 28, 2017 , ... Calibration, ... to ensuring high-quality results and maintaining GMP and USP compliance. In a new ... accordance with GMP requirements " these requirements are explained. The challenge is ...
    (Date:3/28/2017)... , ... March 28, 2017 , ... ... measurement of corrosive ions found in power plant water and steam. , Chlorides ... as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ...
    (Date:3/28/2017)... ... March 28, 2017 , ... ... offered by the American Association of Integrative Medicine and available for application on ... at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president of ...
    (Date:3/28/2017)... ... March 28, 2017 , ... Silicon Valley Hair Institute, the San Francisco ... blog post about women’s hair loss. Although hair transplant procedures can be seen as ... Menopause or genetics can be two reasons a woman may see her hair thinning. ...
    Breaking Medicine News(10 mins):
    (Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Eli Lilly and its partnering interests ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ... deal and company data. The report will be ...
    (Date:3/27/2017)... VANCOUVER, British Columbia , March 27, 2017 /PRNewswire/ ... of Directors has appointed William "Bill" Dubiel as President ... Dubiel was also elected to the Board of Directors ... serve as the Executive Chairman of LightIntegra. ... become LightIntegra,s next President and Chief Executive Officer. We,ve ...
    (Date:3/27/2017)... and VANCOUVER, British Columbia, March 27, 2017 /PRNewswire/ ... (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical ... patients with urological diseases, today reported fourth quarter ... corporate highlights. Key Corporate Highlights: ... Development for Localized Prostate Cancer. During 2016, the ...
    Breaking Medicine Technology: